Inozyme Pharma Inc Ordinary Shares (NASDAQ:INZY)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - INZY
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - INZY
- Market Cap$622.420m
- SymbolNASDAQ:INZY
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS45790W1080
Company Profile
Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, or genetically engineered, fusion protein that is designed to correct a defect in the mineralization pathway caused by ENPP1 and ABCC6 deficiencies.
Latest INZY news
Currently there for this company. Visit our news hub for other news .